Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Zhao, Wei ^a,b   Varghese, Merina ^a,b   Yemul, Shrishailam ^a,b   Pan, Yong ^a,b   Cheng, Alice ^a,b   Marano, Paul ^a   Hassan, Sadiq ^a   Vempati, Prashant ^a,b   Chen, Fei ^a,b   Qian, Xianjuan ^a,b   Pasinetti, Giulio ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; STRESS ACTIVATED PROTEIN KINASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; ELECTRON TRANSPORT; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD; SURVIVAL; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

EID: 79960560886     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-51     Document Type: Article

References (35)

1. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Pasinelli P Brown RH, Nat Rev Neurosci 2006 7 710 723 16924260
2. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Rosen DR Siddique T, Patterson D Figlewicz DA, Sapp P Hentati A, Donaldson D Goto J, O'Regan JP Deng HX, Nature 1993 362 59 62 10.1038/362059a0 8446170 (Pubitemid 23087289)
3. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. Mattiazzi M D'Aurelio M Gajewski CD Martushova K, Kiaei M Beal MF, Manfredi G,, J Biol Chem 2002 277 29626 29633 10.1074/jbc.M203065200 12050154 (Pubitemid 41079252)
4. Mitochondria in sporadic amyotrophic lateral sclerosis. Swerdlow RH Parks JK Cassarino DS Trimmer PA, Miller SW Maguire DJ, Sheehan JP Maguire RS, Pattee G Juel VC, Phillips LH Tuttle JB, Bennett JP Jr Davis RE, Parker WD Jr,, Exp Neurol 1998 153 135 142 10.1006/exnr.1998.6866 9743575 (Pubitemid 28452305)
5. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Gurney ME Pu H, Chiu AY Dal Canto MC, Polchow CY Alexander DD, Caliendo J Hentati A, Kwon YW Deng HX, Science 1994 264 1772 1775 10.1126/science.8209258 8209258 (Pubitemid 24227760)
6. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Bruijn LI Miller TM Cleveland DW,, Annu Rev Neurosci 2004 27 723 749 10.1146/annurev.neuro.27.070203.144244 15217349 (Pubitemid 39050419)
7. Mitochondria and the pathogenesis of ALS. Beal MF, Brain 2000 123 Pt 7 1291 1292 10869044 (Pubitemid 30420932)
8. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Manfredi G Xu Z, Mitochondrion 2005 5 77 87 10.1016/j.mito.2005.01.002 16050975 (Pubitemid 40485768)
9. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. Browne SE Bowling AC, Baik MJ Gurney M, Brown RH Jr Beal MF, J Neurochem 1998 71 281 287 9648876 (Pubitemid 28292560)
10. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. Bowling AC Schulz JB, Brown RH Jr Beal MF, J Neurochem 1993 61 2322 2325 10.1111/j.1471-4159.1993.tb07478.x 8245985 (Pubitemid 23354097)
11. Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells. Fukuchi K Maruyama H, Takagi Y Gomi K, Biochim Biophys Acta 1999 1451 206 210 10.1016/S0167-4889(99) 00081-6 10446402 (Pubitemid 29364260)
12. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. Jung C Higgins CM Xu Z,, J Neurochem 2002 83 535 545 10.1046/j.1471-4159.2002.01112.x 12390515
13. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Klivenyi P Ferrante RJ, Matthews RT Bogdanov MB, Klein AM Andreassen OA, Mueller G Wermer M, Kaddurah-Daouk R Beal MF, Nat Med 1999 5 347 350 10.1038/6568 10086395
14. Metabolic control through the PGC-1 family of transcription coactivators. Lin J Handschin C Spiegelman BM,, Cell Metab 2005 1 361 370 10.1016/j.cmet.2005.05.004 16054085 (Pubitemid 43960626)
15. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Arany Z He H Lin J Hoyer K, Handschin C Toka O, Ahmad F Matsui T, Chin S Wu PH, Rybkin II Shelton JM, Manieri M Cinti S, Schoen FJ Bassel-Duby R, Rosenzweig A Ingwall JS, Spiegelman BM,, Cell Metab 2005 1 259 271 10.1016/j.cmet.2005.03.002 16054070 (Pubitemid 43960608)
16. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Gurney ME Pu H, Chiu AY Dal Canto MC, Polchow CY Alexander DD, Caliendo J Hentati A, Kwon YW Deng HX, Science 1994 264 1772 1775 10.1126/science.8209258 8209258 (Pubitemid 24227760)
17. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Pradat PF Bruneteau G, Gordon PH Dupuis L, Bonnefont-Rousselot D Simon D, Salachas F Corcia P, Frochot V Lacorte JM, Jardel C Coussieu C, Le FN Lacomblez L, Loeffler JP Meininger V, Amyotroph Lateral Scler 2010 11 166 171 10.3109/17482960902822960 20184518
18. A quantitative histochemical assay for activities of mitochondrial electron transport chain complexes in mouse spinal cord sections. Jung C Higgins CM Xu Z,, J Neurosci Methods 2002 114 165 172 10.1016/S0165-0270(01)00524-6 11856567
19. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. Perlson E Jeong GB Ross JL Dixit R, Wallace KE Kalb RG, Holzbaur EL,, J Neurosci 2009 29 9903 9917 10.1523/JNEUROSCI.0813-09.2009 19657041
20. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Tortarolo M Veglianese P, Calvaresi N Botturi A, Rossi C Giorgini A, Migheli A Bendotti C, Mol Cell Neurosci 2003 23 180 192 10.1016/S1044- 7431(03)00022-8 12812752 (Pubitemid 36703155)
21. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Williamson TL Cleveland DW, Nat Neurosci 1999 2 50 56 10.1038/4553 10195180 (Pubitemid 30488940)
22. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Ackerley S Grierson AJ, Banner S Perkinton MS, Brownlees J Byers HL, Ward M Thornhill P, Hussain K Waby JS, Anderton BH Cooper JD, Dingwall C Leigh PN, Shaw CE Miller CC, Mol Cell Neurosci 2004 26 354 364 10.1016/j.mcn.2004.02.009 15207859
23. Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. De VK Severin F Van HF Vancompernolle K, Goossens V Hyman A, Grooten J,, J Cell Biol 2000 149 1207 1214 10.1083/jcb.149.6.1207 10851018 (Pubitemid 30399674)
24. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Morfini G Pigino G, Szebenyi G You Y, Pollema S Brady ST, Nat Neurosci 2006 9 907 916 10.1038/nn1717 16751763 (Pubitemid 43980505)
25. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Zheng B Liao Z, Locascio JJ Lesniak KA, Roderick SS Watt ML, Eklund AC Zhang-James Y, Kim PD Hauser MA, Grunblatt E Moran LB, Mandel SA Riederer P, Miller RM Federoff HJ, Wullner U Papapetropoulos S, Youdim MB Cantuti-Castelvetri I, Young AB Vance JM, Davis RL Hedreen JC, Adler CH Beach TG, Graeber MB Middleton FA, Rochet JC Scherzer CR, Sci Transl Med 2010 2 52ra73 20926834
26. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Qin W Haroutunian V Katsel P Cardozo CP, Ho L Buxbaum JD, Pasinetti GM,, Arch Neurol 2009 66 352 361 10.1001/archneurol.2008.588 19273754
27. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cui L Jeong H, Borovecki F Parkhurst CN, Tanese N Krainc D, Cell 2006 127 59 69 10.1016/j.cell.2006.09.015 17018277 (Pubitemid 44466642)
28. Impaired PGC-1alpha function in muscle in Huntington's disease. Chaturvedi RK Adhihetty P Shukla S Hennessy T, Calingasan N Yang L, Starkov A Kiaei M, Cannella M Sassone J, Ciammola A Squitieri F, Beal MF,, Hum Mol Genet 2009 18 3048 3065 10.1093/hmg/ddp243 19460884
29. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Kiaei M Kipiani K Chen J Calingasan NY, Beal MF,, Exp Neurol 2005 191 331 336 10.1016/j.expneurol. 2004.10.007 15649489 (Pubitemid 40092877)
30. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. Schutz B Reimann J, Dumitrescu-Ozimek L Kappes-Horn K, Landreth GE Schurmann B, Zimmer A Heneka MT, J Neurosci 2005 25 7805 7812 10.1523/JNEUROSCI.2038-05.2005 16120782 (Pubitemid 41208652)
31. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. Qin W Yang T Ho L Zhao Z, Wang J Chen L, Zhao W Thiyagarajan M, MacGrogan D Rodgers JT, Puigserver P Sadoshima J, Deng H Pedrini S, Gandy S Sauve AA, Pasinetti GM,, J Biol Chem 2006 281 21745 21754 10.1074/jbc.M602909200 16751189 (Pubitemid 44181878)
32. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Kelley KA Ho L Winger D Freire-Moar J, Borelli CB Aisen PS, Pasinetti GM,, Am J Pathol 1999 155 995 1004 10.1016/S0002-9440(10)65199-1 10487857 (Pubitemid 29426846)
33. Cresyl violet: a red fluorescent Nissl stain. varez-Buylla A Ling CY Kirn JR,, J Neurosci Methods 1990 33 129 133 10.1016/0165-0270(90)90016-9 2232864
34. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. Brouillet E Guyot MC Mittoux V Altairac S, Conde F Palfi S, Hantraye P,, J Neurochem 1998 70 794 805 9453576
35. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease. Pandey M Varghese M, Sindhu KM Sreetama S, Navneet AK Mohanakumar KP, Usha R, J Neurochem 2008 104 420 434 17953654 (Pubitemid 350293876)